Home › Funds › Brueske Advisory Services, LLC › JNJ

Brueske Advisory Services, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

Brueske Advisory Services, LLC reported holding 1,873 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2025 13F filing — a position valued at US$347K, representing 0.19% of its reported portfolio and ranking #48 among its reported holdings. Brueske Advisory Services, LLC has disclosed JNJ holdings in 4 of the last 4 reported quarters, going back to Q4 2024.

Latest position (Q3 2025)1.87K sh
Reported value held$347.29K
Portfolio Weight0.19%
First reportedQ4 2024
Last changeAdd
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How Brueske Advisory Services, LLC's JNJ position evolved

Brueske Advisory Services, LLC first disclosed a stake in JNJ in Q4 2024 at 1,737 shares (US$251K). The position peaked in Q3 2025 at 1,873 shares, worth US$347K. Across 4 filings, Brueske Advisory Services, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2025) shows 1,873 shares valued at US$347K — an increase of 93 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2024 1.74K $251.21K New
Q1 2025 1.80K $298.18K Add
Q2 2025 1.78K $271.89K Reduce
Q3 2025 1.87K $347.29K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Brueske Advisory Services, LLC held JNJ?

Brueske Advisory Services, LLC has disclosed JNJ holdings in 4 of the last 4 reported quarters, going back to Q4 2024.

What is Brueske Advisory Services, LLC's current position in JNJ?

As of Q3 2025, Brueske Advisory Services, LLC holds 1.87K shares of JNJ (JOHNSON & JOHNSON), valued at $347.29K, representing 0.19% of its reported portfolio and ranking #48.

Has Brueske Advisory Services, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2025), Brueske Advisory Services, LLC increased its position in JNJ. The position peaked in Q3 2025 at 1.87K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.